AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
The current AstraZeneca(AZN) stock price is $170.99, with a market capitalization of 263.67B. The stock trades at a price-to-earnings (P/E) ratio of 25.54 and offers a dividend yield of 1.68%.
As of 2026-10-27, AstraZeneca(AZN) stock has fluctuated between $169.45 and $171.72. The current price stands at $170.99, placing the stock +0.9% above today's low and -0.4% off the high.
The AstraZeneca(AZN)'s current trading volume is 2.91M, compared to an average daily volume of 3.29M.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $153.41.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $153.41.
AZN News
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. The QUARTZ study from AstraZeneca looks at how different add-on rescue options af...
Amgen Inc. (NASDAQ:AMGN) on Saturday released interim Phase 3 trial results showing that Imdelltra, evaluated in combination with AstraZeneca Plc’s (NYSE:AZN) I...
Investing Is AstraZeneca’s Pipeline Fuel Enough to Spark a Post-Earnings Breakout on Oct. 30? AstraZeneca (NYSE:AZN | AZN Price Prediction) reports third-quarte...
Analyst ratings
91%
of 11 ratingsMore AZN News
AstraZeneca is readying to file the first of a new portfolio of targeted cancer drugs for regulatory approval. Hector Retamal / Agence France-Presse / Getty Ima...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is launching a new real-world study tracking selumetinib in adults wi...
The company states: “Alexion, AstraZeneca (AZN) Rare Disease’s Ultomiris – ravulizumab – has been approved in the US to reduce proteinuria in adults with primar...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is sponsoring a new kidney study in China called “China Glomeruloneph...
Novo Nordisk’s (NVO Quick QuoteNVO - Free Report) latest analysis showing its CagriSema injection capable of achieving 25% weight loss in average adult wo...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.